A Prospective Pilot Trial to Assess the Efficacy of Argatroban (Argatra(®)) in Critically Ill Patients with Heparin Resistance †

The current study aims to evaluate whether prophylactic anticoagulation using argatroban or an increased dose of unfractionated heparin (UFH) is effective in achieving the targeted activated partial thromboplastin time (aPTT) of more than 45 s in critically ill heparin-resistant (HR) patients. Patie...

Full description

Saved in:
Bibliographic Details
Published in:J Clin Med
Main Authors: Bachler, Mirjam, Hell, Tobias, Bösch, Johannes, Treml, Benedikt, Schenk, Bettina, Treichl, Benjamin, Friesenecker, Barbara, Lorenz, Ingo, Stengg, Daniel, Hruby, Stefan, Wallner, Bernd, Oswald, Elgar, Ströhle, Mathias, Niederwanger, Christian, Irsara, Christian, Fries, Dietmar
Format: Artigo
Language:Inglês
Published: MDPI 2020
Subjects:
Article
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC7230377/
https://ncbi.nlm.nih.gov/pubmed/32244368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/jcm9040963
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items